You have reached the archives of the Chemical Reaction Database

2022

2023

USPTO examples

  • US20230167117 TLR7 antagonist, Beigene, LTD. 2023 reaction data
  • US20230167127 antimicrobial, Hoffmann-La Roche Inc. 2023 reaction data
  • US20230167131 PAD4 inhibitors Bristol Myers Squibb 2023 reaction data
  • US20230167057 STING inhibitors IFM Due, Inc. 2023 reaction data
  • US20230167119 Adenosine 2B receptor antagonist, Bugworks Research, Inc. 2023 reaction data
  • US20230167148 Aminoglycosides, Revagenix, Inc. 2023 reaction data
  • US20230167118 BTK inhibitor, Beigene, LTD. 2023 reaction data
  • US20230167073 drug for TRPC6-related diseases, Teijin Pharma Limited 2023 reaction data

Older dataset additions

Case study on Molnupiravir synthesis, Covid antiviral medication.

Case study on Remdesivir synthesis, Covid antiviral medication.

Case study on Paxlovid (Nirmatrelvir) synthesis, Covid antiviral medication.